Hatten Head and Neck Photo  Cropped

Head and neck cancers found in the tongue and tonsils are becoming increasingly more common with Human papillomavirus (HPV)-associated throat cancers.  Our physicians are motivated to offer excellent cancer care for these malignancies, while aiming to minimize treatment related side effects. Treatment of head and neck cancers often leave patients with a challenging recovery - including swallowing problems that are significant in the short and long-term. That's why, at the University of Maryland Greenebaum Comprehensive Cancer Center, our multidisciplinary head and neck cancer team is incorporating robotic surgery into the treatment plan to reduce swallowing side effects and optimize quality of life.

Dr. Kyle Hatten, an ear, nose and throat surgeon and Dr. Joshua Lubek an oral maxillofacial surgeon with the University of Maryland, are fellowship-trained in head and neck oncology, microvascular reconstruction and robotic surgery. They regularly perform Transoral Robotic Surgery (TORS) and work collaboratively with our multidisciplinary team to ensure the best treatment plan and outcomes for every patient.

Why Choose Robotic Surgery at UMGCCC:

  • Many patients with HPV-related cancers will qualify minimally invasive transoral robotic surgery.
  • Robotic surgery reduces, and potentially eliminates the need for radiation therapy, and often allows a patient to avoid chemotherapy.
  • Robotic surgery reduces swallowing dysfunction after surgery for many HPV-related cancers
  • Robotic surgery decreases length of hospital stay and recovery time following surgery.
  • Robotic surgery is a less-invasive tool to identify and treat carcinoma of unknown primary in the neck.

Make an Appointment

  • Call 410-706-6195 (Oral & Maxillofacial-Head & Neck Surgery)
  • Call 410-328-6866 (Otorhinolaryngology-Head & Neck Surgery)